308 related articles for article (PubMed ID: 19589050)
1. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.
Schüle C; Baghai TC; Eser D; Rupprecht R
Expert Rev Neurother; 2009 Jul; 9(7):1005-19. PubMed ID: 19589050
[TBL] [Abstract][Full Text] [Related]
2. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
3. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G
Neuro Endocrinol Lett; 2009 Mar; 30(1):11-6. PubMed ID: 19300389
[TBL] [Abstract][Full Text] [Related]
4. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
5. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
6. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B
Pol J Pharmacol; 2002; 54(4):343-9. PubMed ID: 12523487
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrinological mechanisms of actions of antidepressant drugs.
Schüle C
J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
[TBL] [Abstract][Full Text] [Related]
8. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
[TBL] [Abstract][Full Text] [Related]
9. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
Barden N
J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
[TBL] [Abstract][Full Text] [Related]
10. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H; Zimmermann P; Ising M; Kloiber S; Lucae S; Kunzel HE; Binder EB; Holsboer F; Uhr M
Neuropsychobiology; 2007; 55(1):28-35. PubMed ID: 17556850
[TBL] [Abstract][Full Text] [Related]
11. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
12. [The role of the hypothalamo-hypophyseal-adrenocortical system in the specific activity of antidepressive agents].
Arushanian EB; El'bek'ian KS
Eksp Klin Farmakol; 1995; 58(3):65-70. PubMed ID: 7663305
[TBL] [Abstract][Full Text] [Related]
13. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
15. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
Holsboer F; Ising M
Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
[TBL] [Abstract][Full Text] [Related]
16. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats.
Naert G; Maurice T; Tapia-Arancibia L; Givalois L
Psychoneuroendocrinology; 2007; 32(8-10):1062-78. PubMed ID: 17928160
[TBL] [Abstract][Full Text] [Related]
17. The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats.
Szymańska M; Budziszewska B; Jaworska-Feil L; Basta-Kaim A; Kubera M; Leśkiewicz M; Regulska M; Lasoń W
Psychoneuroendocrinology; 2009 Jul; 34(6):822-32. PubMed ID: 19195790
[TBL] [Abstract][Full Text] [Related]
18. Antiglucocoticoid treatments for depression.
Young AH
Aust N Z J Psychiatry; 2006 May; 40(5):402-5. PubMed ID: 16683965
[TBL] [Abstract][Full Text] [Related]
19. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
Nemeroff CB
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-6. PubMed ID: 12404664
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.
Hatzinger M
World J Biol Psychiatry; 2000 Apr; 1(2):105-11. PubMed ID: 12607206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
